<p><b>Foot note</b>: NR not reported, OS overall survival, RFS recurrence-free survival.</p
<p><i>NR</i> not reported, <i>POSI</i> positive, <i>T</i> tumor cells, <i>S</i> stromal cells, <i>CS...
<p>OS: overall survival; DFS: disease-free survival; RFS: recurrence-free survival; CSS: cancer-spec...
<p>OS: overall survival; CSS: cancer-specific survival; RFS: recurrence-free survival; HR: hazard ra...
<p><b>Abbreviations:</b><b>NR</b>, not reported; <b>LS</b>, limited stage; <b>ES</b>, extensive stag...
<p>OS: overall survival; DFS: disease-free survival; PFS: progression-free survival; NR: not reporte...
<p>Abbreviations: NR, not reported; Pre, prediagnosis; Post, postdiagnosis; S, surgery; chemo, chemo...
<p>Note: NR, not report; OS, overall survival.</p><p>Main characteristics of the included studies.</...
<p>NR: Not reported.</p><p>Characteristics of studies included in the meta-analysis.</p
<p>*, included 3 ICC; NLR, neutrophil-to-lymphocyte ratio; NOS, Newcastle–Ottawa Scale; NP, not repo...
<p>Abbreviations: PFS, progression-free survival; OS, overall survival; RCC, renal cell cancer; NSCL...
<p><b>M</b>: male; <b>F</b>: female; <b>AD</b>: adenocarcinoma; <b>SQ</b>: squamous cell carcinoma; ...
<p><b>Abbreviations:</b><b>NR</b>, not reported; <b>SQ</b>, squamous cell cancer; <b>AD</b>, adenoca...
<p>Abbreviations: PFS, progression-free survival; NET, neuroendocrine tumors; RCC, renal cell cancer...
<p>Baseline characteristics of the included studies: Treatment success group vs. AF recurrence group...
Baseline characteristics of the included studies and outcome events in the meta-analysis.</p
<p><i>NR</i> not reported, <i>POSI</i> positive, <i>T</i> tumor cells, <i>S</i> stromal cells, <i>CS...
<p>OS: overall survival; DFS: disease-free survival; RFS: recurrence-free survival; CSS: cancer-spec...
<p>OS: overall survival; CSS: cancer-specific survival; RFS: recurrence-free survival; HR: hazard ra...
<p><b>Abbreviations:</b><b>NR</b>, not reported; <b>LS</b>, limited stage; <b>ES</b>, extensive stag...
<p>OS: overall survival; DFS: disease-free survival; PFS: progression-free survival; NR: not reporte...
<p>Abbreviations: NR, not reported; Pre, prediagnosis; Post, postdiagnosis; S, surgery; chemo, chemo...
<p>Note: NR, not report; OS, overall survival.</p><p>Main characteristics of the included studies.</...
<p>NR: Not reported.</p><p>Characteristics of studies included in the meta-analysis.</p
<p>*, included 3 ICC; NLR, neutrophil-to-lymphocyte ratio; NOS, Newcastle–Ottawa Scale; NP, not repo...
<p>Abbreviations: PFS, progression-free survival; OS, overall survival; RCC, renal cell cancer; NSCL...
<p><b>M</b>: male; <b>F</b>: female; <b>AD</b>: adenocarcinoma; <b>SQ</b>: squamous cell carcinoma; ...
<p><b>Abbreviations:</b><b>NR</b>, not reported; <b>SQ</b>, squamous cell cancer; <b>AD</b>, adenoca...
<p>Abbreviations: PFS, progression-free survival; NET, neuroendocrine tumors; RCC, renal cell cancer...
<p>Baseline characteristics of the included studies: Treatment success group vs. AF recurrence group...
Baseline characteristics of the included studies and outcome events in the meta-analysis.</p
<p><i>NR</i> not reported, <i>POSI</i> positive, <i>T</i> tumor cells, <i>S</i> stromal cells, <i>CS...
<p>OS: overall survival; DFS: disease-free survival; RFS: recurrence-free survival; CSS: cancer-spec...
<p>OS: overall survival; CSS: cancer-specific survival; RFS: recurrence-free survival; HR: hazard ra...
DOI
Add to ORKG